Ten Tips for Launching eSignatures in Clinical Trials While Avoiding Part 11 Risks
Is your eSignature strategy compliant? We've compiled ten tips for launching eSignatures in clinical trials while avoiding Part 11 Risks.
Recent advances in purpose-built eRegulatory solutions employ eSignatures for far more than the basic benefit of reducing paper workflows. However, as with any new technology in clinical trials, it is important to ensure you are getting the most out of eSignatures while remaining fully compliant and secure.
